Terms: = Liver cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
12 results:
1. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract] [Full Text] [Related]
2. MUC1 triggers lineage plasticity of Her2 positive mammary tumors.
Pang Z; Dong X; Deng H; Wang C; Liao X; Liao C; Liao Y; Tian W; Cheng J; Chen G; Yi H; Huang L
Oncogene; 2022 May; 41(22):3064-3078. PubMed ID: 35461328
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite-stable colorectal liver metastases.
Stift J; Graf A; Neudert B; Herac M; Woeran K; Tamandl D; Laengle J; Schwarz C; Wrba F; Kaczirek K; Stremitzer S
HPB (Oxford); 2022 Jan; 24(1):40-46. PubMed ID: 34158230
[TBL] [Abstract] [Full Text] [Related]
4. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.
Ruf B; Heinrich B; Greten TF
Cell Mol Immunol; 2021 Jan; 18(1):112-127. PubMed ID: 33235387
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
Yu S; Wang Y; Hou J; Li W; Wang X; Xiang L; Tan D; Wang W; Jiang L; Claret FX; Jiao M; Guo H
PLoS One; 2020; 15(4):e0231003. PubMed ID: 32240238
[TBL] [Abstract] [Full Text] [Related]
6. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract] [Full Text] [Related]
7. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor outcome in Hepatocellular Carcinoma.
Duan M; Goswami S; Shi JY; Wu LJ; Wang XY; Ma JQ; Zhang Z; Shi Y; Ma LJ; Zhang S; Xi RB; Cao Y; Zhou J; Fan J; Zhang XM; Gao Q
Clin Cancer Res; 2019 Jun; 25(11):3304-3316. PubMed ID: 30723143
[TBL] [Abstract] [Full Text] [Related]
8. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
[TBL] [Abstract] [Full Text] [Related]
9. New therapeutic options for advanced non-resectable malignant melanoma.
Stadler S; Weina K; Gebhardt C; Utikal J
Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
[TBL] [Abstract] [Full Text] [Related]
10. Diabetes worsening of hepatitis C cirrhosis: are alterations in monocytic tissue factor (CD 142) is the cause?
El Makarem MA; Eslam M; Sayed D; Shawkat M; Idriss NK; Soliman EM; Sherif T; Abdelshaheed R; Abdelhailm H; Sahrawi MA; Elheney S
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):27-37. PubMed ID: 24378263
[TBL] [Abstract] [Full Text] [Related]
11. Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.
Navaneethan U; G K Venkatesh P; Lashner BA; Lopez R; Kiran RP; Shen B
J Crohns Colitis; 2012 Jul; 6(6):674-80. PubMed ID: 22398102
[TBL] [Abstract] [Full Text] [Related]
12. [Evaluation of chemosensitivity testing by CD-DST, and TS and DPD activity in cases of colorectal liver].
Tono T; Takahashi H; Kanoh T; Nakano Y; Tamagaki S; Yasue A; Okada K; Matsui S; Iwazawa T; Yano H; Kinuta M; Okamura J; Monden T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1523-6. PubMed ID: 11707970
[TBL] [Abstract] [Full Text] [Related]